Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2026 Filed Mar 18, 2026 22:02 UTC |
Min JohnChief Legal Ofcr & Secretary
|
GrantRestricted Stock Units · Derivative | 303 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000043 · form4.xml · derivative · entry 1 Min John · CIK 0001994515 · Chief Legal Ofcr & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,920 Underlying: Common Stock · 303 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on March 16, 2026. F4 · derivative.exercise_date: The restricted stock units will vest in full on September 16, 2027, subject to Mr. Min's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on September 16, 2027, subject to Mr. Min's continued employment with the Company on the vesting date. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:01 UTC |
Suerken Peter J. JRPresident, U.S.
|
GrantRestricted Stock Units · Derivative | 456 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000042 · form4.xml · derivative · entry 2 Suerken Peter J. JR · CIK 0002079685 · President, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,051 Underlying: Common Stock · 456 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on March 16, 2026. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. Suerken's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. Suerken's continued employment with the Company on the applicable vesting date. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 22:01 UTC |
Suerken Peter J. JRPresident, U.S.
|
GrantRestricted Stock Units · Derivative | 2,840 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000042 · form4.xml · derivative · entry 1 Suerken Peter J. JR · CIK 0002079685 · President, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,595 Underlying: Common Stock · 2,840 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on March 16, 2026. F4 · derivative.exercise_date: The restricted stock units will vest in full on July 22, 2027, subject to Mr. Suerken's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on July 22, 2027, subject to Mr. Suerken's continued employment with the Company on the vesting date. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:59 UTC |
Arlin Wendy C.Director
|
GrantRestricted Stock Units · Derivative | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000041 · form4.xml · derivative · entry 2 Arlin Wendy C. · CIK 0001876592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,204 Underlying: Common Stock · 291 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · shares: Represents dividend equivalent units issued on March 16, 2026. F4 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of May 21, 2026 or the date of the Company's 2026 annual meeting of stockholders. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company. F4 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of May 21, 2026 or the date of the Company's 2026 annual meeting of stockholders. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:59 UTC |
Arlin Wendy C.Director
|
GrantRestricted Stock Units · Derivative | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000041 · form4.xml · derivative · entry 1 Arlin Wendy C. · CIK 0001876592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,913 Underlying: Common Stock · 201 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · shares: Represents dividend equivalent units issued on March 16, 2026. F3 · derivative.exercise_date: The restricted stock units vested in full on May 21, 2025. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company. F3 · derivative.expiration_date: The restricted stock units vested in full on May 21, 2025. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:59 UTC |
Dolan Kristin ADirector
|
GrantRestricted Stock Units · Derivative | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000040 · form4.xml · derivative · entry 1 Dolan Kristin A · CIK 0001480991 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,901 Underlying: Common Stock · 291 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · shares: Represents dividend equivalent units issued on March 16, 2026. F3 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of May 21, 2026 or the date of the Company's 2026 annual meeting of stockholders. Vested shares will be delivered upon Ms. Dolan's termination as a director of the Company. F3 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of May 21, 2026 or the date of the Company's 2026 annual meeting of stockholders. Vested shares will be delivered upon Ms. Dolan's termination as a director of the Company. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:57 UTC |
Cook Kenneth M.Interim CEO and CFO
|
GrantRestricted Stock Units · Derivative | 3,045 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000039 · form4.xml · derivative · entry 3 Cook Kenneth M. · CIK 0002046945 · Interim CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,810 Underlying: Common Stock · 3,045 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on March 16, 2026. F6 · derivative.exercise_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Mr. Cook's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Mr. Cook's continued employment with the Company on the applicable vesting date. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:57 UTC |
Cook Kenneth M.Interim CEO and CFO
|
GrantRestricted Stock Units · Derivative | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000039 · form4.xml · derivative · entry 2 Cook Kenneth M. · CIK 0002046945 · Interim CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,765 Underlying: Common Stock · 340 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on March 16, 2026. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. Cook's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. Cook's continued employment with the Company on the applicable vesting date. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:57 UTC |
Cook Kenneth M.Interim CEO and CFO
|
GrantRestricted Stock Units · Derivative | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000039 · form4.xml · derivative · entry 1 Cook Kenneth M. · CIK 0002046945 · Interim CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,425 Underlying: Common Stock · 356 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on March 16, 2026. F4 · derivative.exercise_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:15 UTC |
O'Brien Matthew ColeyChief People Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 18,598 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000025 · form4.xml · derivative · entry 3 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,218 Underlying: Common Stock · 18,598 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: With tandem dividend equivalent rights and tax withholding rights. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Includes 2,833 dividend equivalent units that had accrued on the restricted stock units. F4 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023, and fully vested (including the related dividend equivalent units) on March 1, 2026. F4 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023, and fully vested (including the related dividend equivalent units) on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:15 UTC |
O'Brien Matthew ColeyChief People Officer
|
Tax withholdingCommon Stock | 5,690 | $7.66 | $43,585.40 |
DisclosureSEC source: 0000030697-26-000025 · form4.xml · nonDerivative · entry 2 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,587 Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:15 UTC |
O'Brien Matthew ColeyChief People Officer
|
Exercise / conversionCommon Stock | 18,598 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000025 · form4.xml · nonDerivative · entry 1 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:23 UTC |
Spessard Matthew PChief Information Officer
|
Tax withholdingCommon Stock | 858 | $7.77 | $6,666.66 |
DisclosureSEC source: 0000030697-26-000023 · form4.xml · nonDerivative · entry 2 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,748 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:23 UTC |
Spessard Matthew PChief Information Officer
|
GrantCommon Stock | 2,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000023 · form4.xml · nonDerivative · entry 1 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,606 F1 · shares: Reflects settlement of performance units granted to Mr. Spessard in February 2023 as part of the Company's long-term incentive plan. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:19 UTC |
Thuerk Suzanne M.Chief Accounting Officer
|
Tax withholdingCommon Stock | 576 | $7.77 | $4,475.52 |
DisclosureSEC source: 0000030697-26-000022 · form4.xml · nonDerivative · entry 2 Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,619 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:19 UTC |
Thuerk Suzanne M.Chief Accounting Officer
|
GrantCommon Stock | 1,673 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000022 · form4.xml · nonDerivative · entry 1 Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,195 F1 · shares: Reflects settlement of performance units granted to Ms. Thuerk in February 2023 as part of the Company's long-term incentive plan. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:18 UTC |
Wunsch E.J.President, International
|
Tax withholdingCommon Stock | 4,141 | $7.77 | $32,175.57 |
DisclosureSEC source: 0000030697-26-000021 · form4.xml · nonDerivative · entry 2 Wunsch E.J. · CIK 0001685884 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,628 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:18 UTC |
Wunsch E.J.President, International
|
GrantCommon Stock | 12,278 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000021 · form4.xml · nonDerivative · entry 1 Wunsch E.J. · CIK 0001685884 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,769 F1 · shares: Reflects settlement of performance units granted to Mr. Wunsch in February 2023 as part of the Company's long-term incentive plan. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:11 UTC |
O'Brien Matthew ColeyChief People Officer
|
Tax withholdingCommon Stock | 2,688 | $7.77 | $20,885.76 |
DisclosureSEC source: 0000030697-26-000020 · form4.xml · nonDerivative · entry 2 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,679 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:11 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000020 · form4.xml · nonDerivative · entry 1 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,367 F1 · shares: Reflects settlement of performance units granted to Mr. O'Brien in February 2023 as part of the Company's long-term incentive plan. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:06 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
Tax withholdingCommon Stock | 2,358 | $7.77 | $18,321.66 |
DisclosureSEC source: 0000030697-26-000019 · form4.xml · nonDerivative · entry 2 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,049 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:06 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantCommon Stock | 6,976 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000019 · form4.xml · nonDerivative · entry 1 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,407 F1 · shares: Reflects settlement of performance units granted to Ms. Esposito in February 2023 as part of the Company's long-term incentive plan. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:05 UTC |
Radkoski Lindsay J.CMO, U.S.
|
Tax withholdingCommon Stock | 864 | $7.77 | $6,713.28 |
DisclosureSEC source: 0000030697-26-000018 · form4.xml · nonDerivative · entry 2 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,948 Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 22:05 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantCommon Stock | 2,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000018 · form4.xml · nonDerivative · entry 1 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,812 F1 · shares: Reflects settlement of performance units granted to Ms. Radkoski in February 2023 as part of the Company's long-term incentive plan. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:04 UTC |
Spessard Matthew PChief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,481 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000017 · form4.xml · derivative · entry 3 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,690 Underlying: Common Stock · 3,481 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: With tandem dividend equivalent rights and tax withholding rights. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Includes 201 dividend equivalent units that had accrued on the restricted stock units. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on February 20, 2027 and 2028, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on February 20, 2027 and 2028, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:04 UTC |
Spessard Matthew PChief Information Officer
|
Tax withholdingCommon Stock | 1,189 | $8.09 | $9,619.01 |
DisclosureSEC source: 0000030697-26-000017 · form4.xml · nonDerivative · entry 2 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,095 Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 22:04 UTC |
Spessard Matthew PChief Information Officer
|
Exercise / conversionCommon Stock | 3,481 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-26-000017 · form4.xml · nonDerivative · entry 1 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 22:07 UTC |
Dolan Kristin ADirector
|
GrantCommon Stock | 1,564 | $8.37 | $13,090.68 |
DisclosureSEC source: 0000030697-26-000004 · form4.xml · nonDerivative · entry 1 Dolan Kristin A · CIK 0001480991 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,708 F1 · kind: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a portion of Ms. Dolan's quarterly Board of Directors retainer fee and quarterly Board committee retainer fees that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 22:04 UTC |
Peltz Bradley G.Director
|
GrantCommon Stock | 2,942 | $8.37 | $24,624.54 |
DisclosureSEC source: 0000030697-26-000003 · form4.xml · nonDerivative · entry 1 Peltz Bradley G. · CIK 0002078112 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,012 F1 · kind: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of Mr. Peltz's quarterly Board of Directors retainer fee and quarterly Board committee retainer fees that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:45 UTC |
MAY PETER WDirector · 10% owner
|
GrantCommon Stock | 5,704 | $8.37 | $47,742.48 |
DisclosureSEC source: 0001193125-26-006457 · ownership.xml · nonDerivative · entry 1 MAY PETER W · CIK 0000928264 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,537,881 F1 · acquired: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a quarterly Board of Directors retainer fee and a quarterly Board committee retainer fee that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:36 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 1,024 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000065 · form4.xml · derivative · entry 4 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,586 Underlying: Common Stock · 1,024 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F7 · derivative.exercise_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. F7 · derivative.expiration_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:36 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 205 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000065 · form4.xml · derivative · entry 3 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,562 Underlying: Common Stock · 205 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:36 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 74 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000065 · form4.xml · derivative · entry 2 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,357 Underlying: Common Stock · 74 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:36 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 29 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000065 · form4.xml · derivative · entry 1 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,283 Underlying: Common Stock · 29 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F4 · derivative.exercise_date: The restricted stock units will vest in one remaining installment on August 11, 2026, subject to Ms. Esposito's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in one remaining installment on August 11, 2026, subject to Ms. Esposito's continued employment with the Company on the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:34 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 1,216 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000064 · form4.xml · derivative · entry 5 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,816 Underlying: Common Stock · 1,216 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F8 · derivative.exercise_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. F8 · derivative.expiration_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:34 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000064 · form4.xml · derivative · entry 4 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,600 Underlying: Common Stock · 243 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F7 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. F7 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:34 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000064 · form4.xml · derivative · entry 3 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,357 Underlying: Common Stock · 85 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F6 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:34 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000064 · form4.xml · derivative · entry 2 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,272 Underlying: Common Stock · 31 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F5 · derivative.exercise_date: The restricted stock units will vest in one remaining installment on August 11, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in one remaining installment on August 11, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:34 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000064 · form4.xml · derivative · entry 1 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,241 Underlying: Common Stock · 312 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F4 · derivative.exercise_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:33 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 896 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000063 · form4.xml · derivative · entry 7 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,956 Underlying: Common Stock · 896 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F10 · derivative.exercise_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F10 · derivative.expiration_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:33 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000063 · form4.xml · derivative · entry 6 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,060 Underlying: Common Stock · 179 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F9 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F9 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:33 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 532 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000063 · form4.xml · derivative · entry 5 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,881 Underlying: Common Stock · 532 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F8 · derivative.exercise_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date. F8 · derivative.expiration_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:33 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 89 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000063 · form4.xml · derivative · entry 4 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,349 Underlying: Common Stock · 89 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F7 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 15, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F7 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 15, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:33 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000063 · form4.xml · derivative · entry 3 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,260 Underlying: Common Stock · 35 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F6 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:33 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000063 · form4.xml · derivative · entry 2 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,225 Underlying: Common Stock · 147 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F5 · derivative.exercise_date: The restricted stock units will vest in full on December 7, 2026, subject to Ms. Radkoski's continued employment with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in full on December 7, 2026, subject to Ms. Radkoski's continued employment with the Company on the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:33 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000063 · form4.xml · derivative · entry 1 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,078 Underlying: Common Stock · 11 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F4 · derivative.exercise_date: The restricted stock units will vest in one remaining installment on August 11, 2026, subject to Ms. Radkoski's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in one remaining installment on August 11, 2026, subject to Ms. Radkoski's continued employment with the Company on the vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:32 UTC |
Spessard Matthew PChief Information Officer
|
GrantRestricted Stock Units · Derivative | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000062 · form4.xml · derivative · entry 5 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,171 Underlying: Common Stock · 736 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F8 · derivative.exercise_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. F8 · derivative.expiration_date: The restricted stock units will vest in two equal installments on August 12, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:32 UTC |
Spessard Matthew PChief Information Officer
|
GrantRestricted Stock Units · Derivative | 148 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000062 · form4.xml · derivative · entry 4 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,435 Underlying: Common Stock · 148 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F7 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. F7 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 12, 2026, 2027 and 2028, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:32 UTC |
Spessard Matthew PChief Information Officer
|
GrantRestricted Stock Units · Derivative | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000062 · form4.xml · derivative · entry 3 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,287 Underlying: Common Stock · 175 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on February 20, 2026, 2027 and 2028, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on February 20, 2026, 2027 and 2028, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:32 UTC |
Spessard Matthew PChief Information Officer
|
GrantRestricted Stock Units · Derivative | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0000030697-25-000062 · form4.xml · derivative · entry 2 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,112 Underlying: Common Stock · 39 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 15, 2025. F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 5, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.